candoxatrilat has been researched along with Hypoxia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, JM; Winter, RJ; Zhao, L | 2 |
| Hughes, JM; Krausz, T; Winter, RJ; Zhao, L | 1 |
3 other study(ies) available for candoxatrilat and Hypoxia
| Article | Year |
|---|---|
Reversal of pulmonary vascular remodelling following hypoxic exposure: no effect of infusion of atrial natriuretic factor and neutral endopeptidase inhibitor.
Topics: Animals; Atrial Natriuretic Factor; Cyclohexanecarboxylic Acids; Hematocrit; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Muscle, Smooth, Vascular; Neprilysin; Rats; Rats, Wistar; Time Factors | 1994 |
Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung.
Topics: Animals; Atrial Natriuretic Factor; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Drug Interactions; Hypoxia; Male; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Rats; Rats, Wistar; Vasoconstriction; Vasodilation | 1992 |
Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclohexanecarboxylic Acids; Hypertension, Pulmonary; Hypoxia; Male; Neprilysin; Pulmonary Artery; Rats; Rats, Inbred Strains | 1991 |